long noncoding rna gihcg induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer

Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide, however, the mechanisms of CRC progression remain obscure. The present study investi-gated the clinical significance and functional role of long noncoding RNA (lncRNA) GIHCG in CRC. Methods: Expression of GIHCG was detected by quantitative real time polymerase chain reaction (qRT-PCR) in seven CRC cell lines and 110 GIHCG may be a promising prognostic biomarker and therapeutic target in CRC.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  Long Ma,et al.  Long noncoding RNA GIHCG enhanced tongue squamous cell carcinoma progression through regulating miR‐429 , 2018, Journal of cellular biochemistry.

[3]  C. Cavaliere,et al.  Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma. , 2018, European review for medical and pharmacological sciences.

[4]  O. Slabý,et al.  Therapeutic targeting of non-coding RNAs in cancer. , 2017, The Biochemical journal.

[5]  P. Khavari,et al.  The functions and unique features of long intergenic non-coding RNA , 2017, Nature Reviews Molecular Cell Biology.

[6]  Yongzhi Yang,et al.  Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions , 2017, Journal of Cancer.

[7]  Y. Kondo,et al.  Long non‐coding RNAs as an epigenetic regulator in human cancers , 2017, Cancer science.

[8]  A. Bhan,et al.  Long Noncoding RNA and Cancer: A New Paradigm. , 2017, Cancer research.

[9]  Yvonne Tay,et al.  Long noncoding RNAs: lincs between human health and disease. , 2017, Biochemical Society transactions.

[10]  Ying Su,et al.  Long non-coding RNAs: New biomarkers for prognosis and diagnosis of colon cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[11]  D. Glavač,et al.  Long Noncoding RNAs as Biomarkers in Cancer , 2017, Disease markers.

[12]  M. Dinger,et al.  The regulatory role of long noncoding RNAs in cancer. , 2017, Cancer letters.

[13]  T. Rajkumar,et al.  Perspectives of long non-coding RNAs in cancer , 2017, Molecular Biology Reports.

[14]  Q. Qu,et al.  Long non-coding RNAs: a rising biotarget in colorectal cancer , 2017, Oncotarget.

[15]  Chunyang Jiang,et al.  Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis , 2016, Molecular Cancer.

[16]  A. Chinnaiyan,et al.  The bright side of dark matter: lncRNAs in cancer. , 2016, The Journal of clinical investigation.

[17]  P. Ross,et al.  Colorectal adenocarcinoma: risks, prevention and diagnosis , 2016, British Medical Journal.

[18]  Jiamei Yang,et al.  Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429 , 2016, Journal of Molecular Medicine.

[19]  M. Dinger,et al.  Long noncoding RNAs in cancer: mechanisms of action and technological advancements , 2016, Molecular Cancer.

[20]  Y. Ben-Neriah,et al.  Inflammatory networks underlying colorectal cancer , 2016, Nature Immunology.

[21]  Fiona Powrie,et al.  Emerging cytokine networks in colorectal cancer , 2015, Nature Reviews Immunology.

[22]  R. Tuli,et al.  Review of systemic therapies for locally advanced and metastatic rectal cancer. , 2015, Journal of gastrointestinal oncology.

[23]  J. Hurley,et al.  The molecular genetics of colorectal cancer , 2013, Frontline Gastroenterology.

[24]  S. Kern,et al.  Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward? , 2008, Cancer biology & therapy.

[25]  S. Groshen,et al.  Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  R. James,et al.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.

[27]  J W Arends,et al.  Molecular interactions in the Vogelstein model of colorectal carcinoma , 2000, The Journal of pathology.

[28]  B. Shan,et al.  MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease. , 2017, Methods in molecular biology.

[29]  A. Morillon,et al.  History, Discovery, and Classification of lncRNAs. , 2017, Advances in experimental medicine and biology.

[30]  Subash Chandra Gupta,et al.  Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets , 2017, International journal of cancer.

[31]  Chandrasekhar Kanduri,et al.  Long Noncoding RNA: Genome Organization and Mechanism of Action. , 2017, Advances in experimental medicine and biology.

[32]  D. Ahlquist,et al.  Colorectal Adenomas. , 2016, The New England journal of medicine.